OptimalTTF-1: Enhancing tumor treating fields therapy with skull remodeling surgery. A clinical phase I trial in adult recurrent glioblastoma

BACKGROUND: Preclinical studies suggest that skull remodeling surgery (SR-surgery) increases the dose of tumor treating fields (TTFields) in glioblastoma (GBM) and prevents wasteful current shunting through the skin. SR-surgery introduces minor skull defects to focus the cancer-inhibiting currents t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurooncol Adv
Autors principals: Korshoej, Anders Rosendal, Lukacova, Slavka, Lassen-Ramshad, Yasmin, Rahbek, Christian, Severinsen, Kåre Eg, Guldberg, Trine Lignell, Mikic, Nikola, Jensen, Mette Haldrup, Cortnum, Søren Ole Stigaard, von Oettingen, Gorm, Sørensen, Jens Christian Hedemann
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7660275/
https://ncbi.nlm.nih.gov/pubmed/33215088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa121
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars